Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dylan Hansen

Showing results (21-30 of 60) with videos related to

Pageof 6
Sort By:
Arthritis Care & Research|February 8, 2024
Inflammatory Arthritis in Systemic Sclerosis: Its Epidemiology, Associations, and MorbidityEric Schwender, Dylan Hansen, Wendy Stevens, et al.
Clinical Rheumatology|November 3, 2023
The effect of calcium channel blockers on digital ulcers in systemic sclerosis: data from a prospective cohort studyLaura Ross, Dylan Hansen, Nancy Maltez, et al.
Journal of Scleroderma and Related Disorders|May 26, 2025
Frequency and determinants of use of immunosuppressants in the Australian Scleroderma Cohort StudyJessica L Fairley, Dylan Hansen, Susanna Proudman, et al.
Journal of Scleroderma and Related Disorders|August 25, 2025
Clinical associations of worsening physical function as measured by HAQ-DI scores in systemic sclerosisJessica L Fairley, Dylan Hansen, Susanna Proudman, et al.
Arthritis Care & Research|September 21, 2019
Incidence, Risk Factors, and Outcomes of Cancer in Systemic SclerosisKathleen Morrisroe, Dylan Hansen, Molla Huq, et al.
Seminars in Arthritis and Rheumatism|November 26, 2022
Disease specific determinants of cardiopulmonary fitness in systemic sclerosisLaura Ross, Benedict Costello, Anniina Lindqvist, et al.
Clinical Rheumatology|October 1, 2025
Prevalence, clinical characteristics, and hospital course of systemic sclerosis-associated pseudo-obstructionLaura Ross, Lyman Lin, Dylan Hansen, et al.
ACR Open Rheumatology|April 22, 2025
The Prognostic and Functional Impact of Multimorbidity in Systemic SclerosisJessica L Fairley, Dylan Hansen, Susanna Proudman, et al.
Rheumatology (Oxford, England)|February 17, 2024
Multiple serum biomarkers associate with mortality and interstitial lung disease progression in systemic sclerosisMatthew James Sinclair Parker, Adelle S Jee, Dylan Hansen, et al.
Arthritis Research & Therapy|April 12, 2022
Using magnetic resonance imaging to map the hidden burden of muscle involvement in systemic sclerosisLaura Ross, Anniina Lindqvist, Benedict Costello, et al.
Pageof 6

Showing results (21-30 of 60) with videos related to

Sort By:
Pageof 6
Arthritis Care & Research|February 8, 2024
Inflammatory Arthritis in Systemic Sclerosis: Its Epidemiology, Associations, and MorbidityEric Schwender, Dylan Hansen, Wendy Stevens, et al.
Clinical Rheumatology|November 3, 2023
The effect of calcium channel blockers on digital ulcers in systemic sclerosis: data from a prospective cohort studyLaura Ross, Dylan Hansen, Nancy Maltez, et al.
Journal of Scleroderma and Related Disorders|May 26, 2025
Frequency and determinants of use of immunosuppressants in the Australian Scleroderma Cohort StudyJessica L Fairley, Dylan Hansen, Susanna Proudman, et al.
Journal of Scleroderma and Related Disorders|August 25, 2025
Clinical associations of worsening physical function as measured by HAQ-DI scores in systemic sclerosisJessica L Fairley, Dylan Hansen, Susanna Proudman, et al.
Arthritis Care & Research|September 21, 2019
Incidence, Risk Factors, and Outcomes of Cancer in Systemic SclerosisKathleen Morrisroe, Dylan Hansen, Molla Huq, et al.
Seminars in Arthritis and Rheumatism|November 26, 2022
Disease specific determinants of cardiopulmonary fitness in systemic sclerosisLaura Ross, Benedict Costello, Anniina Lindqvist, et al.
Clinical Rheumatology|October 1, 2025
Prevalence, clinical characteristics, and hospital course of systemic sclerosis-associated pseudo-obstructionLaura Ross, Lyman Lin, Dylan Hansen, et al.
ACR Open Rheumatology|April 22, 2025
The Prognostic and Functional Impact of Multimorbidity in Systemic SclerosisJessica L Fairley, Dylan Hansen, Susanna Proudman, et al.
Rheumatology (Oxford, England)|February 17, 2024
Multiple serum biomarkers associate with mortality and interstitial lung disease progression in systemic sclerosisMatthew James Sinclair Parker, Adelle S Jee, Dylan Hansen, et al.
Arthritis Research & Therapy|April 12, 2022
Using magnetic resonance imaging to map the hidden burden of muscle involvement in systemic sclerosisLaura Ross, Anniina Lindqvist, Benedict Costello, et al.
Pageof 6